Submitted: 04 Sep 2022
Accepted: 01 Oct 2022
ePublished: 08 Oct 2022
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Ren Endocrinol. 2022;8: e21063.
doi: 10.34172/jre.2022.21063
  Abstract View: 270
  PDF Download: 198


COVID-19 in systemic lupus erythematosus; a mini-review on current knowledge

Mahsa Rafieian 1 ORCID logo, Hamid Nasri 2* ORCID logo, Yassamin Rabiei 1 ORCID logo

1 Nickan Research Institute, Isfahan, Iran.
2 Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
*Corresponding Author: Corresponding Author: Prof. Hamid Nasri, Email: hamidnasri@yahoo.com, , Email: hamidnasri@med.mui.ac.ir


The consequences of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection vary among persons, while some individuals are at high risk. Patients with systemic lupus erythematosus (SLE) and COVID-19 necessitate particular attention. SLE cases may be at particular risk for SARS-CoV-2 due to their dysregulated immune system and immunosuppressive treatments. Organ injury and administration of systemic glucocorticoids and other immunosuppressive agents are the risk factors for severe SARS-CoV-2. Additionally, SLE is not uncommon and could be severe in some ethnicities like African and Hispanic individuals and may be accompanied by poor outcomes of SARS-CoV-2. Thus, knowledge of the triggering immune response and therapeutic modalities in SLE and SARS-CoV-2 is necessary to guide treatment of this serious infectious disease in the background of SLE and vice versa.

Citation: Rafieian M, Nasri H, Rabiei Y. COVID-19 in systemic lupus erythematosus; a mini-review on current knowledge. J Ren Endocrinol. 2022;8:e21063. doi: 10.34172/jre.2022.21063.
First Name
Last Name
Email Address
Security code

Abstract View: 270

Your browser does not support the canvas element.

PDF Download: 198

Your browser does not support the canvas element.